TOBACCO CONTROL CONTINUING EDUCATION FOR PHYSICIANS

这项SBIR快速通道申请建议开发、评估和实施基于互联网的继续教育（CE）计划，向初级保健医生和住院医生教授烟草控制技术。CE项目将通过互联网提供，包括临床场景、医生提供给患者的信息以及讨论功能（通过公告栏）。匹兹堡大学将提供CE学分。该项目将开发一套8门课程。在第一阶段，我们将创建一个原型课程，其中将包括一个直接的临床场景，涉及患者和医生，其中显示了筛查和干预。我们还将开发和评估评估工具，以衡量课程的效果。我们将在一项简单的随机评估研究中评估原型和仪器，将使用烟草控制课程的受试者与使用其他主题的CE课程的受试者进行比较。项目二期将完成其他7门课程，并在6个月的时间内对所有课程进行评估，以调查一系列课程的效益，并评估长期的潜在效益。建议的商业应用：医生需要获得CME学分以维持执照和特权。医生可能会被要求在讨论这一重要公共卫生问题的课程中获得CE学分。管理式医疗组织（mco），例如大型hmo，可能有兴趣购买可以提供给参与专业人员的CE访问权限，特别是对所有医生有用的主题的CE。制药公司可能还希望支持基于此应用程序中使用的模型的课程开发。

This SBIR fast-track application proposes to develop, evaluate, and implement an Internet-based continuing education (CE) program to teach primary care physicians and residents about tobacco control techniques. The CE program will be available via the Internet and will include clinical scenarios, information for physicians to give to patients, and discussion capability (via bulletin boards). The University of Pittsburgh will provide CE credit. The project will develop a suite of 8 courses. In Phase I we will create a prototype course that will include a straightforward clinical scenario involving a patient and physician where screening and intervention is indicated. We will also develop and evaluate assessment instruments to measure the effect of the courses. We will assess the prototype and instruments in a simple randomized evaluation study comparing subjects using the tobacco control course to subjects using a CE course on another topic. Phase II of the project will complete the seven other courses, and evaluate all courses over a six month period to investigate the benefit of a series of courses and evaluate potential benefit over time. PROPOSED COMMERCIAL APPLICATIONS: Physicians are required to obtain CME credit to maintain licensure and privileges. Physicians may be urged to obtain CE credit on a course that discusses this important public health issue. Managed care organizations (MCOs), such as large HMOs, may be interested in purchasing access to CE that can be offered to participant professionals especially CE on a topic useful for all physicians. Pharmaceutical companies may also want to support development of courses based on the model used in this application.